Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
WEBAug 23, 2021 · The Pfizer-BioNTech COVID-19 Vaccine has received EUA from FDA to: prevent COVID-19 in individuals 12 years of age and older, and; provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise
Pfizer and BioNTech Announce Phase 3 Trial Data Showing High …
WEBOct 21, 2021 · NEW YORK & MAINZ, Germany-- (BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a 30-µg booster dose of the Pfizer-BioNTech COVID-19 Vaccine in more than 10,000 individuals 16 …
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBAug 22, 2024 · Unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated, authorized Pfizer-BioNTech COVID-19 Vaccine or two doses of the updated,...
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron …
WEBSep 20, 2024 · NEW YORK & MAINZ, Germany, September 20, 2024--Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use ...
FDA Approves First COVID-19 Vaccine
WEBFDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the prevention of COVID-19 disease...
US FDA authorizes Pfizer-BioNTech and Moderna's updated …
WEBSept 11 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday authorized updated COVID-19 vaccines from Pfizer (PFE.N) /BioNTech (22UAy.DE) and Moderna (MRNA.O) that target a...
Pfizer and BioNTech Confirm High Efficacy and No Serious Safety ...
WEBApr 1, 2021 · Analysis of 927 confirmed symptomatic cases of COVID-19 demonstrates BNT162b2 is highly effective with 91.3% vaccine efficacy observed against COVID-19, measured seven days through up to six months after the second dose. Vaccine was 100% effective in preventing severe disease as defined by the U.S. Centers for Disease Control and Prevention and ...
Pfizer’s Stock Faces Challenges as Oxbryta Recall Impacts Drug …
WEB1 day ago · Bansal notes the significant negative impact of the recall on Pfizer’s discounted cash flow (DCF), which is estimated to be a reduction of $1 per share or a 3.5% decrease.
Pfizer and BioNTech Announce Further Details on …
WEBApr 9, 2020 · Pfizer and BioNTech to jointly develop COVID-19 vaccine, initially in the United States and Europe, and scale-up manufacturing capacity to support global supply.
Pfizer's updated COVID-19 vaccine approved, Health Canada says
WEB3 days ago · Both the latest Pfizer and Moderna vaccines are approved for adults and for children six months of age and older. Novavax is approved for adults and those aged 12 years and up. Pfizer-BioNTech's ...
- Some results have been removed